BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29721729)

  • 21. Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.
    Campbell BK; Le T; Tajima B; Guydish J
    J Subst Abuse Treat; 2017 Feb; 73():40-46. PubMed ID: 28017183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs.
    Keating S; Larsen SE; Collingwood J; Smith HM
    J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The New York policy on smoking in addiction treatment: findings after 1 year.
    Guydish J; Tajima B; Kulaga A; Zavala R; Brown LS; Bostrom A; Ziedonis D; Chan M
    Am J Public Health; 2012 May; 102(5):e17-25. PubMed ID: 22420814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking intervention with adolescent substance abusers. Initial recommendations.
    Myers MG
    J Subst Abuse Treat; 1999 Jun; 16(4):289-98. PubMed ID: 10349601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment.
    Martin RA; Rohsenow DJ; MacKinnon SV; Abrams DB; Monti PM
    Drug Alcohol Depend; 2006 Jun; 83(1):73-8. PubMed ID: 16314049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting nicotine addiction in a substance abuse program.
    Sharp JR; Schwartz S; Nightingale T; Novak S
    Sci Pract Perspect; 2003 Aug; 2(1):33-40. PubMed ID: 18552720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco Cessation Interventions and Smoke-Free Policies in Mental Health and Substance Abuse Treatment Facilities - United States, 2016.
    Marynak K; VanFrank B; Tetlow S; Mahoney M; Phillips E; Jamal Mbbs A; Schecter A; Tipperman D; Babb S
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(18):519-523. PubMed ID: 29746451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do total smoking bans affect the recruitment and retention of adolescents in inpatient substance abuse treatment programs? A 5-year medical chart review, 2001-2005.
    Callaghan RC; Brewster JM; Johnson J; Taylor L; Beach G; Lentz T
    J Subst Abuse Treat; 2007 Oct; 33(3):279-85. PubMed ID: 17376637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoting smoke-free environments and tobacco cessation in residential treatment facilities for mental health and substance addictions, Oregon, 2010.
    Drach LL; Morris D; Cushing C; Romoli C; Harris RL
    Prev Chronic Dis; 2012; 9():E23. PubMed ID: 22172190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of tobacco-free policy on recruitment and retention of adolescents in residential substance abuse treatment.
    Kempf J; Stanley A
    J Addict Dis; 1996; 15(2):1-11. PubMed ID: 8703997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of and Factors Related to Tobacco Ban Implementation in Substance Use Disorder Treatment Programs.
    Muilenburg JL; Laschober TC; Eby LT; Moore ND
    Adm Policy Ment Health; 2016 Mar; 43(2):241-9. PubMed ID: 25677250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative exploration of family perspectives of smoke-free mental health and addiction services.
    Missen RL; Brannelly T; Newton-Howes G
    Int J Ment Health Nurs; 2013 Aug; 22(4):294-303. PubMed ID: 23066762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organization-Level Factors Associated with Changes in the Delivery of the Five A's for Smoking Cessation following the Implementation of a Comprehensive Tobacco-Free Workplace Program within Substance Use Treatment Centers.
    LoParco CR; Chen TA; Martinez Leal I; Britton M; Carter BJ; Correa-Fernández V; Kyburz B; Williams T; Casey K; Rogova A; Lin HC; Reitzel LR
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking Cessation for Those Pursuing Recovery from Substance Use Disorders.
    Derefinko KJ; Salgado García FI; Sumrok DD
    Med Clin North Am; 2018 Jul; 102(4):781-796. PubMed ID: 29933829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients.
    Guydish J; Le T; Hosakote S; Straus E; Wong J; Martínez C; Delucchi K
    J Subst Abuse Treat; 2022 Jan; 132():108496. PubMed ID: 34111773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of treatment of nicotine dependence during an inpatient substance abuse treatment program.
    Joseph AM; Nichol KL; Willenbring ML; Korn JE; Lysaght LS
    JAMA; 1990 Jun; 263(22):3043-6. PubMed ID: 2342215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking Behaviors and Attitudes Among Clients and Staff at New York Addiction Treatment Programs Following a Smoking Ban: Findings After 5 Years.
    Pagano A; Guydish J; Le T; Tajima B; Passalacqua E; Soto-Nevarez A; Brown LS; Delucchi KL
    Nicotine Tob Res; 2016 May; 18(5):1274-81. PubMed ID: 26014456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involuntary smoking cessation: a treatment option in chemical dependency programs for women and children.
    Ker M; Leischow S; Markowitz IB; Merikle E
    J Psychoactive Drugs; 1996; 28(1):47-60. PubMed ID: 8714334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intention to quit tobacco use among clients in substance use disorder treatment settings.
    Moore D; Langlois M; Gerber BM; Gaddis R; Hallam JS; Arnold R
    Subst Use Misuse; 2007; 42(5):871-9. PubMed ID: 17613950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.